No matter either CD4+ T cell count less than 200/μL or 400/μL was used as a marker of immune deficiency, there were no differences in the renal function and the prevalence of the anti-GBM antibodies between groups (Table 3). The gene discussed is CD4; the disease is Immunodeficiency.